Plenhyage XL Medium 2ml

Plenhyage XL Medium 2ml is an advanced biorevitalization injectable formulated to reverse the early signs of chronological aging, improve viscoelasticity, and optimize dermal hydration. Utilizing highly purified, polymerised polynucleotides (PN), this innovative treatment operates at a cellular level to drive deep tissue regeneration, reinforce the extracellular matrix (ECM) architecture, and enhance overall skin density.

By delivering a targeted molecular weight of DNA fractions directly into the dermis, Plenhyage XL Medium activates adenosine A2A receptors, which triggers fibroblast proliferation and up-regulates the production of endogenous Type I collagen and elastin. This medium-viscosity formulation is specifically engineered to treat moderate cutaneous sagging, superficial rhytids, and early tissue atrophy, promoting a smoother, firmer, and more resilient dermal structure.

As a highly versatile modality in regenerative aesthetics, Plenhyage XL Medium offers medical practitioners an evidence-based solution for progressive, natural-looking physiological rejuvenation and preventative anti-aging treatments.

Key Benefits:

Targeted Fibroblast Activation: Triggers the synthesis of high-quality collagen and elastin to rebuild weakening dermal scaffolding.
Optimized Viscoelastic Hydration: Binds water molecules within the extracellular matrix to deliver deep, prolonged hydro-balance.
Corrects Moderate Cutaneous Laxity: Smooths out superficial lines, early wrinkles, and fine rhytids without adding artificial volume.
Refines Dermal Architecture: Improves overall skin tone, cellular texture, and physiological thickness from within.
Trophic Tissue Repair: Promotes natural cell turnover, cellular regeneration, and rapid repair of photo-damaged skin.

Ideal Clinical Treatment Areas:

Full face (addressing initial volume loss or early superficial sagging).
Neck (treating early horizontal rings and skin laxity).
Décolleté rejuvenation and smoothing of sleep-lines.
Dorsal hands exhibiting early dermal thinning and volume loss.

Product Specifications:

Volume: 2ml sterile, prefilled glass syringe.
Rheological Profile: Medium viscosity, high-purity polymerised polynucleotides.
Indication: Moderate skin laxity, fine lines, early-stage elastosis, and structural prevention.
Classification: CE-marked medical device intended for professional clinical use only.

Usage:

For professional use only. Must be administered via intradermal microinjections, linear threading, or advanced mesotherapy protocols by qualified medical practitioners using sterile techniques.